Courses

Welcome to the Pediatric Pulmonary Hypertension classroom. CME activities are available at no charge to registered users of the site. Not a registered user? Register now for free.

*Note: If you wish to be notified when new courses on issues related to pediatric pulmonary hypertension are added, make sure you're logged-in and click "Subscribe" to the left.

To report any technical issues, please email PHAOnlineUniv@PHAssociation.org

 

Pulmonary Hypertension Specific Inhaled Therapy

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Apr 19 2012
Activity Expiration Date: 
Sep 1 2011

In this recording from the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, Erika Berman-Rosenzweig, MD discusses the current inhaled therapies available for the treatment of pulmonary hypertension. Special attention is paid to the possibility for inhaled therapies to be used in critical care settings especially with pediatric and neonatal populations.

Pulmonary Hypertension Specific Oral Therapy

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Apr 19 2012
Activity Expiration Date: 
Sep 1 2011

In this recording from the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, Ingram Schulze-Neick, MD, PhD discusses the current oral therapies available for the treatment of pulmonary hypertension with specific attention paid to the evidence for use in pediatric patients where available.

Pulmonary Hypertension on the Indian Subcontinent

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Jan 19 2012
Activity Expiration Date: 
Sep 1 2012

At the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, S. Ramakrishnan, MD, DM, AIIMS presented this lecture about the state of pulmonary hypertension in India, a country that has a vastly underdiagnosed population of patients suffering from congenital heart disease.  He discusses how the general barriers to effective health care play out in the field of pulmonary hypertension.

Pulmonary Hypertension Associated with Hemolytic Disorders

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Jan 19 2012
Activity Expiration Date: 
Sep 1 2012

At the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conferece, Mark Gladwin, MD presented this lecture on the different hemolytic conditions seen in pulmonary hypertension. This includes the way that hemolytic conditions may affect nitric oxide signaling and the impact on survival.

Update on Eisenmenger Syndrome: The Role of Specific Pulmonary Hypertension Therapies

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Jan 19 2012
Activity Expiration Date: 
Sep 1 2012

Dr. Gary Webb gave this update on Eisenmenger Syndromes and the specific therapies related to pulmonary hypertension at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  This presentation covers the definition and causes of Eisenmenger syndrome as well as issues involved with pulmonary artery banding.

Emerging Pharmacological Treatment Approaches/Novel Pathways: Strengths, Gaps, Unmet Needs

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Jan 19 2012
Activity Expiration Date: 
Sep 1 2012

Dr. Robyn Barst discusses the future of pulmonary hypertension therapies in this presentation from the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  From tyrosine kinase inhibitors to inhaled nitrous oxide and the many opportunities for treatment currently under research.

Diagnosis of Pulmonary Hypertension in Children

Course Image: 
Credit type: 
Physician
Credit Hours: 
1.00
Activity Release Date: 
Aug 16 2011
Activity Expiration Date: 
Oct 31 2013

Dunbar Ivy, MD, brings his years of expertise treating pediatric pulmonary hypertension patients to this course which explores the clinical presentation and diagnostic evaluation of both neonates and children with pulmonary hypertension. Dr. Ivy discusses the different uses of diagnostic testing in children with PH from electrocardiography to ventilation-perfusion scintigraphy.

Pulmonary Hypertension Specific Intravenous Therapy

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Dunbar Ivy, MD presented this overview of the intravenous therapies specific to pulmonary hypertension at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Ivy covers intravenous Epoprostenol, subcutaneous and intravenous Treprostinil as well as combination therapy.

Pulmonary Hypertension Caused by Pulmonary Venous Hypertension

Course Image: 
Credit type: 
Physician
Credit Hours: 
1.00
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Thomas Kulik, MD presented this session on pulmonary hypertension when it is caused byt pulmonary venous disease at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.

Pulmonary Arteriovenous Malformations After the Bidirectional Glenn and the Role of Vascular Endothelial Growth Factor

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Narayanswami Sreeram, MD, presented this session on pulmonary arteriovenous malformations after the bidirectional glenn at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Sreeram also discusses the role of vascualr endothelial growth factor.

Optimizing the Transition From the Pediatric to the Adult Congenital Heart Disease Clinic

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

At the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, Andrew Mackie, MD presented this session which discusses the intricacies of transitioning adolescent patients from pediatric to adult care.  Physician facilitation of this transition is important to the continued care of patients once they graduate from pediatric care.

Inducible Intrapulmonary Arteriovenous Shunt Pathways

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Marlowe Eldridge, MD presented this session at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  In this recording Dr. Eldridge discusses how inducible intrapulmonary arteriovenous shunt pathways may challenge conventional wisdom.

Hepatopulmonary Sydrome

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

In this presentation from the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference, Stephen Archer, MD describes the role for DC68(+) macrophages in the etiology of hepatopulmonary syndrome and how macrophage depletion can cause a reversal. This is especially relevant to pulmonary hypertension as this can transition to portopulmonary hypertension following liver transplantation.

Preoperative Assessment of the Patient with an Elevated Pulmonary Vascular Resistance

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Daniel Penny, MD, presented this session on the need for preoperative assessment and the difficulties in getting an accurate assessment at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  He also discusses the difficulty in determining an absolute threshold between operable and inoperable patients.

Genetics of Pulmonary Hypertension

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

As part of the preceedings at the 4th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference, Nicholas Morrell presented this session on the genetic involvement in hereditary pulmonary hypertension.  Dr. Morrell discusses how the expression of the BMPR2 mutation affects the physiological progression of pulmonary hypertension.

Endothelial Progenitor Cells and Chronic Neonatal Pulmonary Hypertension

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Bernard Thebaud, MD presented this session at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Thebaud discusses the role of angiogenesis in lung development.  This session also focuses on emerging cell based theropies using vacular progenitor cells for pulmonary hypertension therapies. 

Persistent Pulmonary Hypertension of the Newborn: Radical Thoughts About Oxygen

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.75
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Robin H. Steinhorn, MD presented this session at the 4th International Neonatal and Childhood Pulmonary Vascular Disease Conference.  Dr. Steinhorn also discusses the current goals of oxygen therapy and new ideas about the continued use of oxygen therapy. This presentation describes the effects of elevated FiO2 on vascular structure and reactivity as well as the pathways of generation and signaling reactive oxygen species.

Filed in:

Chronic Thromboembolic Pulmonary Hypertension

Course Image: 
Credit type: 
Physician
Credit Hours: 
0.50
Activity Release Date: 
Oct 5 2011
Activity Expiration Date: 
Sep 1 2012

Stuart Jamieson, MB, FRCS, MD gave this presentation on Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at the 4th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference.  This presentation discussing the keys to diagnosis as well as the incidence and prevalence of this under recognized condition.  Dr. Jamiesen also discusses the classification of operative specimens as well as the specifics of dealing with pulmonary endarterectomy.

 

 

PHA Online University is a program of the PHA Medical Education Fund. The technical development of this website was made possible through unrestricted medical education grants from Actelion, Gilead, Pfizer and United Therapeutics.